Your browser doesn't support javascript.
loading
Novel Benchmark Values for Redo Liver Transplantation: Does the Outcome Justify the Effort?
Abbassi, Fariba; Gero, Daniel; Muller, Xavier; Bueno, Alba; Figiel, Wojciech; Robin, Fabien; Laroche, Sophie; Picard, Benjamin; Shankar, Sadhana; Ivanics, Tommy; van Reeven, Marjolein; van Leeuwen, Otto B; Braun, Hillary J; Monbaliu, Diethard; Breton, Antoine; Vachharajani, Neeta; Bonaccorsi Riani, Eliano; Nowak, Greg; McMillan, Robert R; Abu-Gazala, Samir; Nair, Amit; Bruballa, Rocio; Paterno, Flavio; Weppler Sears, Deborah; Pinna, Antonio D; Guarrera, James V; de Santibañes, Eduardo; de Santibañes, Martin; Hernandez-Alejandro, Roberto; Olthoff, Kim; Ghobrial, R Mark; Ericzon, Bo-Göran; Ciccarelli, Olga; Chapman, William C; Mabrut, Jean-Yves; Pirenne, Jacques; Müllhaupt, Beat; Ascher, Nancy L; Porte, Robert J; de Meijer, Vincent E; Polak, Wojciech G; Sapisochin, Gonzalo; Attia, Magdy; Soubrane, Olivier; Weiss, Emmanuel; Adam, René A; Cherqui, Daniel; Boudjema, Karim; Zieniewicz, Krzysztof; Jassem, Wayel.
Afiliação
  • Abbassi F; Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.
  • Gero D; Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.
  • Muller X; Department of General, Abdominal and Transplant Surgery, Croix-Rousse Hospital, Lyon, France.
  • Bueno A; Institute of Liver Studies, Kings' College Hospital, London, UK.
  • Figiel W; Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
  • Robin F; Department of HPB Surgery and Transplantation, University Hospital Rennes, Rennes, France.
  • Laroche S; Department of Surgery and Transplantation, the Hepatobiliary Center at Paul Brousse Hospital, Villejuif, France.
  • Picard B; Department of Anesthesiology, Critical Care and Perioperative Medicine, DMU PARABOL, APHP.Nord, Hôpital Beaujon, Clichy, France.
  • Shankar S; Department of Abdominal Transplant and Hepatobiliary Surgery, The Leeds Teaching Hospital trust, Leeds, UK.
  • Ivanics T; Multi-Organ Transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada.
  • van Reeven M; Department of Surgery, Henry Ford Hospital, Detroit, MI.
  • van Leeuwen OB; Department of Surgical Sciences, Akademiska Sjukhuset, Uppsala University, Uppsala, Sweden.
  • Braun HJ; Department of Surgery, Division of HPB & Transplant Surgery, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Monbaliu D; Division of HPB Surgery and Liver Transplantation, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.
  • Breton A; Division of Transplant Surgery, University of California, San Francisco, CA.
  • Vachharajani N; Department of Abdominal Transplant Surgery and Transplant Coordination. University Hospitals Leuven, Leuven, Belgium.
  • Bonaccorsi Riani E; Department of General, Abdominal and Transplant Surgery, Croix-Rousse Hospital, Lyon, France.
  • Nowak G; Division of Abdominal Transplantation, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO.
  • McMillan RR; Department of Abdominal and Transplant Surgery, University Hospital St. Luc, Brussels, Belgium.
  • Abu-Gazala S; Department of Transplantation Surgery, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Nair A; Houston Methodist Hospital, Weill Cornell Medical Center, Houston, TX.
  • Bruballa R; Department of Surgery, Penn Transplant Institute, Hospital of the University of Pennsylvania, Philadelphia, PA.
  • Paterno F; Division of Transplantation and Hepatobiliary Surgery, University of Rochester, Rochester, MN.
  • Weppler Sears D; HPB and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Pinna AD; Division of Liver Transplant, Rutgers New Jersey Medical School University Hospital, Newark, NJ.
  • Guarrera JV; Department of Abdominal and Transplant Surgery, Cleveland Clinic Florida, Weston, FL.
  • de Santibañes E; Department of Abdominal and Transplant Surgery, Cleveland Clinic Florida, Weston, FL.
  • de Santibañes M; Division of Liver Transplant, Rutgers New Jersey Medical School University Hospital, Newark, NJ.
  • Hernandez-Alejandro R; HPB and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Olthoff K; HPB and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Ghobrial RM; Division of Transplantation and Hepatobiliary Surgery, University of Rochester, Rochester, MN.
  • Ericzon BG; Department of Surgery, Penn Transplant Institute, Hospital of the University of Pennsylvania, Philadelphia, PA.
  • Ciccarelli O; Houston Methodist Hospital, Weill Cornell Medical Center, Houston, TX.
  • Chapman WC; Department of Transplantation Surgery, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Mabrut JY; Department of Abdominal and Transplant Surgery, University Hospital St. Luc, Brussels, Belgium.
  • Pirenne J; Division of Abdominal Transplantation, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO.
  • Müllhaupt B; Department of General, Abdominal and Transplant Surgery, Croix-Rousse Hospital, Lyon, France.
  • Ascher NL; Department of Abdominal Transplant Surgery and Transplant Coordination. University Hospitals Leuven, Leuven, Belgium.
  • Porte RJ; Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
  • de Meijer VE; Division of Transplant Surgery, University of California, San Francisco, CA.
  • Polak WG; Division of HPB Surgery and Liver Transplantation, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.
  • Sapisochin G; Division of HPB Surgery and Liver Transplantation, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.
  • Attia M; Department of Surgery, Division of HPB & Transplant Surgery, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Soubrane O; Multi-Organ Transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Weiss E; Department of Abdominal Transplant and Hepatobiliary Surgery, The Leeds Teaching Hospital trust, Leeds, UK.
  • Adam RA; Department of HPB surgery and liver transplantation, DMU DIGEST, APHP.Nord, Hôpital Beaujon, Clichy, France.
  • Cherqui D; Department of Anesthesiology, Critical Care and Perioperative Medicine, DMU PARABOL, APHP.Nord, Hôpital Beaujon, Clichy, France.
  • Boudjema K; Department of Surgery and Transplantation, the Hepatobiliary Center at Paul Brousse Hospital, Villejuif, France.
  • Zieniewicz K; Department of Surgery and Transplantation, the Hepatobiliary Center at Paul Brousse Hospital, Villejuif, France.
  • Jassem W; Department of HPB Surgery and Transplantation, University Hospital Rennes, Rennes, France.
Ann Surg ; 276(5): 860-867, 2022 11 01.
Article em En | MEDLINE | ID: mdl-35894428
ABSTRACT

OBJECTIVE:

To define benchmark cutoffs for redo liver transplantation (redo-LT).

BACKGROUND:

In the era of organ shortage, redo-LT is frequently discussed in terms of expected poor outcome and wasteful resources. However, there is a lack of benchmark data to reliably evaluate outcomes after redo-LT.

METHODS:

We collected data on redo-LT between January 2010 and December 2018 from 22 high-volume transplant centers. Benchmark cases were defined as recipients with model of end stage liver disease (MELD) score ≤25, absence of portal vein thrombosis, no mechanical ventilation at the time of surgery, receiving a graft from a donor after brain death. Also, high-urgent priority and early redo-LT including those for primary nonfunction (PNF) or hepatic artery thrombosis were excluded. Benchmark cutoffs were derived from the 75th percentile of the medians of all benchmark centers.

RESULTS:

Of 1110 redo-LT, 373 (34%) cases qualified as benchmark cases. Among these cases, the rate of postoperative complications until discharge was 76%, and increased up to 87% at 1-year, respectively. One-year overall survival rate was excellent with 90%. Benchmark cutoffs included Comprehensive Complication Index CCI ® at 1-year of ≤72, and in-hospital and 1-year mortality rates of ≤13% and ≤15%, respectively. In contrast, patients who received a redo-LT for PNF showed worse outcomes with some values dramatically outside the redo-LT benchmarks.

CONCLUSION:

This study shows that redo-LT achieves good outcome when looking at benchmark scenarios. However, this figure changes in high-risk redo-LT, as for example in PNF. This analysis objectifies for the first-time results and efforts for redo-LT and can serve as a basis for discussion about the use of scarce resources.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Obtenção de Tecidos e Órgãos / Transplante de Fígado / Doença Hepática Terminal Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Obtenção de Tecidos e Órgãos / Transplante de Fígado / Doença Hepática Terminal Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article